Andrew Elliott

1.1k total citations
99 papers, 483 citations indexed

About

Andrew Elliott is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Andrew Elliott has authored 99 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 39 papers in Molecular Biology. Recurrent topics in Andrew Elliott's work include Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Ferroptosis and cancer prognosis (13 papers). Andrew Elliott is often cited by papers focused on Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Ferroptosis and cancer prognosis (13 papers). Andrew Elliott collaborates with scholars based in United States, Austria and Australia. Andrew Elliott's co-authors include W. Michael Korn, Ari M. Vanderwalde, Kelsey Poorman, Geoffrey T. Gibney, R. W. Knowles, A. A. Epenetos, K. E. Britton, Walter F. Bodmer, C.C. Nimmon and L. A. Hawkins and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Andrew Elliott

78 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Elliott United States 10 260 191 146 89 65 99 483
Greg Friberg United States 10 189 0.7× 259 1.4× 116 0.8× 95 1.1× 50 0.8× 15 488
Tae Sung Ahn South Korea 15 294 1.1× 255 1.3× 119 0.8× 105 1.2× 39 0.6× 45 602
Frédérique Penault‐Llorca France 11 310 1.2× 148 0.8× 83 0.6× 79 0.9× 93 1.4× 21 465
George Au‐Yeung Australia 15 463 1.8× 297 1.6× 119 0.8× 103 1.2× 34 0.5× 43 707
Marye J. Boers‐Sonderen Netherlands 14 346 1.3× 194 1.0× 114 0.8× 43 0.5× 54 0.8× 43 523
Angel Qin United States 12 343 1.3× 178 0.9× 201 1.4× 122 1.4× 25 0.4× 33 561
F. De Vita Italy 11 405 1.6× 198 1.0× 196 1.3× 220 2.5× 85 1.3× 37 691
Andrea Ravelli Italy 10 288 1.1× 200 1.0× 251 1.7× 106 1.2× 23 0.4× 15 543
Oriol Arpí Spain 15 376 1.4× 359 1.9× 126 0.9× 149 1.7× 64 1.0× 24 710
Elisa De Camilli Italy 14 133 0.5× 156 0.8× 86 0.6× 126 1.4× 53 0.8× 27 447

Countries citing papers authored by Andrew Elliott

Since Specialization
Citations

This map shows the geographic impact of Andrew Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Elliott more than expected).

Fields of papers citing papers by Andrew Elliott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Elliott. The network helps show where Andrew Elliott may publish in the future.

Co-authorship network of co-authors of Andrew Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Elliott. A scholar is included among the top collaborators of Andrew Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Elliott. Andrew Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McKay, Rana R., Shayan Nazari, Andrew Elliott, et al.. (2025). Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer. The Oncologist. 30(11).
2.
Groisberg, Roman, Andrew Elliott, Don S. Dizon, et al.. (2025). Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma. Clinical Cancer Research. 31(11). 2210–2221.
3.
Elliott, Andrew, César Serrano, Margaret von Mehren, et al.. (2025). DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas. Cancers. 17(12). 1962–1962. 1 indexed citations
4.
Sen, Utsav, Charles Coleman, Nishant Gandhi, et al.. (2025). SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma. Cancer Research. 85(13). 2485–2503. 11 indexed citations
5.
Puri, Dhruv, Umang Swami, Georges Gebrael, et al.. (2024). PD09-05 DIFFERENCES IN GENOMIC, TRANSCRIPTOMIC AND IMMUNE LANDSCAPE OF PROSTATE CANCER (PCA) BASED ON SITE OF METASTASIS (METS). The Journal of Urology. 211(5S). 1 indexed citations
6.
Italiano, Antoine, Jonathan C. Trent, George W. Sledge, et al.. (2024). 75MO Atlas of tertiary lymphoid structures in solid tumors: Genomic features and prediction of response to immunotherapy. Annals of Oncology. 35. S244–S244. 1 indexed citations
7.
Adeyelu, Tolulope, Andrew Elliott, Farah Abdulla, et al.. (2024). Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma. npj Precision Oncology. 8(1). 187–187. 7 indexed citations
8.
Pan, Elizabeth, Andrew Elliott, Shankar Siva, et al.. (2024). Characterization of FOLH1 Expression in Renal Cell Carcinoma. Cancers. 16(10). 1855–1855. 1 indexed citations
9.
Elliott, Andrew, Wendy Cozen, Evanthia T. Roussos Torres, et al.. (2024). Survival and mutational differences based on ESR1 and ESR2 expression in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8526–8526. 1 indexed citations
10.
Espinoza, Magdalena, Andrew Elliott, Joanne Xiu, et al.. (2024). Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers. Nature Cancer. 5(7). 1121–1129. 11 indexed citations
11.
Elliott, Andrew, Yasmine Baca, Mark E. Reeves, et al.. (2024). Unlocking therapeutic potential: IL-1β as a target in non-small cell lung cancer with oncogenic mutations—Prognostic and predictive insights.. Journal of Clinical Oncology. 42(16_suppl). 8030–8030. 1 indexed citations
12.
Luo, Jia, Mark G. Evans, Tolulope Adeyelu, et al.. (2024). Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma. JCO Precision Oncology. 8(8). e2400334–e2400334. 2 indexed citations
13.
Choi, Sharon H., Elizabeth Pan, Andrew Elliott, et al.. (2024). Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer. Molecular Cancer Research. 22(10). 920–931. 1 indexed citations
14.
Hanna, Glenn J., Punita Grover, Andrew Elliott, et al.. (2024). Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II. Clinical Cancer Research. 30(10). 2225–2232. 6 indexed citations
15.
Wei, Shuanzeng, Daniel M. Geynisman, Andrew Elliott, et al.. (2023). Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas. Modern Pathology. 37(2). 100404–100404. 7 indexed citations
16.
Sammons, Sarah, Andrew Elliott, Romualdo Barroso‐Sousa, et al.. (2023). Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer. Frontiers in Oncology. 13. 1235902–1235902. 4 indexed citations
17.
Florou, Vaia, Andrew Elliott, Matthew H. Bailey, et al.. (2023). Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC. Clinical Cancer Research. 29(17). 3408–3417. 10 indexed citations
18.
Darabi, Sourat, Andrew Elliott, Jia Zeng, et al.. (2022). Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions. Cancers. 14(6). 1505–1505. 4 indexed citations
19.
Freire, Andrea P. Espejo, Andrew Elliott, Andrew E. Rosenberg, et al.. (2021). Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis. Cancers. 13(19). 4816–4816. 44 indexed citations
20.
McDermott, Ray, Emmanuel S. Antonarakis, Christopher Hoimes, et al.. (2020). KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC). European Urology Open Science. 19. e885–e886. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Greg Friberg Breakdown of academic impact, for papers by Tae Sung Ahn Breakdown of academic impact, for papers by Frédérique Penault‐Llorca Breakdown of academic impact, for papers by George Au‐Yeung Breakdown of academic impact, for papers by Marye J. Boers‐Sonderen Breakdown of academic impact, for papers by Angel Qin Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Andrea Ravelli Breakdown of academic impact, for papers by Oriol Arpí Breakdown of academic impact, for papers by Elisa De Camilli
Rankless by CCL
2026